Profiel
Lies Vanneste is currently the Director-Investor Relations at Sequana Medical NV since 2018.
Prior to this, Vanneste worked as the Director-Investor Relations at Ablynx NV.
Actieve functies van Lies Vanneste
| Bedrijven | Functie | Begin |
|---|---|---|
| SEQUANA MEDICAL N.V. | Investor Relations Contact | 01-07-2018 |
Eerdere bekende functies van Lies Vanneste
| Bedrijven | Functie | Einde |
|---|---|---|
| ABLYNX | Investor Relations Contact | 01-06-2018 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SEQUANA MEDICAL N.V. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Ablynx NV
 Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
